Chondroplasty Market: Analysis of Key Developments || Johnson & Johnson, F. Hoffmann-La Roche Ltd., Osiris Therapeutics Inc., Thermo Fisher Scientific Inc

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company presents an extensive market research report on the Chondroplasty Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.

Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities, providing all necessary data for thriving in the industry. This report market research offers a comprehensive perspective, including an in-depth analysis of the present and future scenarios within the industry.

Market Sizing:

The chondroplasty market size has grown strongly in recent years. It will grow from $12.92 billion in 2023 to $13.77 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increased sports-related injuries, patient preference for non-total joint replacement, postoperative care advances, healthcare provider training and expertise, increasing incidence of joint disorders..

The chondroplasty market size is expected to see strong growth in the next few years. It will grow to $17.29 billion in 2028 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to regenerative medicine integration, focus on outpatient procedures, introduction of novel biomaterials, rise in musculoskeletal disorders, expansion of geriatric population.. Major trends in the forecast period include technological integration in rehabilitation, arthroscopic techniques, cartilage repair and regeneration, technological innovations in surgical tools, integration of navigation systems..

Request for free sample report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=13185&type=smp

Key Market Players:

Johnson & Johnson, F. Hoffmann-La Roche Ltd., Osiris Therapeutics Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Medtronic Public Limited Company, Stryker Corporation, Teva Pharmaceutical Industries Ltd., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Sigma-Aldrich Corporation, Arthrex Inc., Bio-Rad Laboratories Inc, QIAGEN N.V., CONMED Corporation, Promega Corporation, Organogenesis Holdings Inc., Bioventus LLC, RTI Surgical Holdings Inc., Vericel Corporation, Geistlich Pharma AG, Ocugen Inc., MEDIPOST Co. Ltd., GPC Medical Ltd., Sklar Surgical Instruments, Isto Biologics, Nebula Inc., NuOrtho Surgical Inc., Medical Devices Business Services Inc. are prominent players in the industry.

Market Drivers:

The rising incidence of joint-related disorders is expected to propel the growth of the chondroplasty market going forward. Joint disorders are diseases that affect the health and function of a joint caused by overuse of a joint or a sudden injury, such as an accident or a sports injury. Chondroplasty treats joint-related disorders by repairing the damaged cartilage in a joint. For instance, in August 2023, according to the data published by The Lancet, a UK-based book and periodic data publishing organization, the incidence of gout, an inflammatory arthritis affecting joints, rose from 1.40 diagnoses per 1,000 adults in March 2021 to 1.44 diagnoses per 1,000 adults in March 2022 in the UK. Further, in June 2023, according to the Centers for Disease Control and Prevention, a US-based national public health agency, it is estimated that 78.4 million (25.9%) US adults aged 18 years or older are expected to have doctor-diagnosed arthritis (BRFSS) by 2040. Therefore, the rising incidence of joint-related disorders is driving the growth of the chondroplasty market going forward.

Learn More About The Market Report - https://www.thebusinessresearchcompany.com/report/chondroplasty-global-market-report

Market Segments Include:
1) By Type: Radiofrequency Ablation Chondroplasty, Abrasion Chondroplasty, Atellar Chondroplasty, Meniscal Repair, Tissue Removal, Other Types
2) By Anatomy: Knee, Shoulder, Hip, Other Anatomies
3) By Equipment: Shavers, Radiofrequency Devices, Arthroscope, Other Equipments
4) By End Use: Hospitals, Orthopedic Clinics, Academic Research, Other End Uses

The report answers the following questions:
What are the primary factors propelling the market during the projected period?

In which region is the most substantial growth expected?

Which trend will take center stage in the upcoming period?

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.